IPTILBY
LIVE

Serial Number

79440400

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IPTILBY Trademark

Serial Number: 79440400

IPTILBY is a trademark filed by Novartis AG on November 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis AG

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

November 12, 2025

Registration Date

Not Registered

Published for Opposition

February 24, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Feb 19, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 4, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 3, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2026 CNSA
ASSIGNED TO EXAMINER
Jan 25, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 16, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2026 NWOS
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 13, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 13, 2026 COAR
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 11, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 1, 2026 REPR